Helping young women in South Africa access HIV prevention options after experiencing partner violence.
Meeting South African adolescent girls and young women who experience intimate partner violence where they are: Developing an implementation strategy for linkage to PrEP options
This study is all about helping young girls and women in South Africa who have faced partner violence by finding better ways for them to access HIV prevention methods, like PrEP, so they can take charge of their health and feel empowered.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10991502 on NIH RePORTER |
What this research studies
This research aims to support adolescent girls and young women in South Africa who have experienced intimate partner violence (IPV) by developing strategies to connect them with HIV prevention methods, specifically pre-exposure prophylaxis (PrEP). The project will explore existing public health resources, such as rape crisis centers, to create pathways for these young women to access long-acting PrEP options. By integrating HIV prevention discussions into IPV care, the research seeks to empower these individuals and improve their sexual health outcomes. The approach involves formative work to understand the needs and barriers faced by this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescent girls and young women in South Africa who have experienced intimate partner violence.
Not a fit: Patients who do not experience intimate partner violence or are outside the age range of 15-24 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to HIV prevention for young women affected by intimate partner violence.
How similar studies have performed: Previous research has shown success in integrating health services for vulnerable populations, indicating potential for this approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Giovenco, Danielle — Emory University
- Study coordinator: Giovenco, Danielle
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.